Market Overview

Benzinga's Top Upgrades

Related TEVA
Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest Revenue
Teva Reports Results of Strategic Review, Sees 14 Pipeline Projects Possible for Divestment, Discontinuation
Sofinnova Ventures Closes $500M Fund (Fox Business)
Related JASO
CNBC's Stock Pops & Drops From August 20
Markets Mostly Higher Despite Initial Negative Reaction From FOMC Minutes
Making Money With Charles Payne: 10/10/14 (Fox Business)

Analysts at Morgan Stanley upgraded Teva Pharmaceutical Industries (NYSE: TEVA) from “underweight” to “equal-weight.” The price target for Teva Pharmaceutical is set to $52. Teva Pharmaceutical's shares closed at $47.96 yesterday.

Axiom upgraded JA Solar Holdings Co (NASDAQ: JASO) from “undefined” to “buy.” The price target for JA Solar is set to $16. JA Solar's shares closed at $10.55 yesterday.

Analysts at Keefe Bruyette & Woods upgraded Independent Bank (NASDAQ: INDB) from “market perform” to “outperform.” The price target for Independent Bank has been raised from $40 to $44. Independent Bank's shares closed at $38.11 yesterday.

Oppenheimer upgraded Lowe's Companies (NYSE: LOW) from “market perform” to “outperform.” The price target for Lowe's Companies has been raised from $50 to $57. Lowe's shares closed at $48.71 yesterday.

Latest Ratings for TEVA

DateFirmActionFromTo
Oct 2014Standpoint ResearchUpgradesHoldBuy
Oct 2014Standpoint ResearchDowngradesBuyHold
Aug 2014UBSMaintainsNeutral

View More Analyst Ratings for TEVA
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (INDB + JASO)

Around the Web, We're Loving...

Get Benzinga's Newsletters